Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0RC0H
|
||||
Former ID |
DIB016806
|
||||
Drug Name |
NPY Y5 antagonists
|
||||
Synonyms |
NPY Y5 antagonists (obesity, depression); NPY Y5 antagonists (obesity, depression), GlaxoSmithKline
|
||||
Indication | Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10:F32, F33, M32] | Investigative | [552083] | ||
Company |
GlaxoSmithKline plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1cccc(c1F)n1ccc(NC[C@@H]2CC[C@@]3(OC(=O)N(c4cccnn4)C3)<br />CC2)n1
|
||||
Target and Pathway | |||||
Target(s) | Neuropeptide Y receptor 5 | Target Info | Antagonist | [543759] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.